@ Bendunstan I agree with your sentiments. In regard...

@ Bendunstan I agree with your sentiments. In regard non-dilutive funding for the stroke / traumatic brain injury work its almost a "no-brainer" (hehe) that positive GLP and Walter Reed outcomes will attract funds from potentially various entities. For TBI I'd bet a penny to a pound that the US Dept of Defense will provide a grant to further the trials into Phase 2/3. TBI has been identified by the DOD as a major issue for them. The Walter Reed facility is the DOD's medical research centre. Big pharma will also take notice and may well want a seat at the table, in particular for the stroke side of things. The risk/reward scenario here is very compelling for NYR given the low market cap presently